Understanding biological driver mutations and mechanism of resistance to EGFR-tyrosine kinase inhibitors in lung cancer patients using a novel translational platform.

2019

e20555Background: Lung cancer causes ~1.69 million deaths globally and 5-year survival rate is 50% cases lung cancers ...

Keywords:

References

Citations